INTS Intensity Therapeutics, Inc. - Common Stock
$4,54
Fiyat · May 20, 2026
Temel veriler itibarıyla May 7, 2026
52 Haftlık Aralık
$0–$8
55% of range
Analist Derecelendirmesi
BUY
12 analysts
Fiyat Hedefi
$42
+814% upside
P/E (TTM)
-0.0
ROE
-165.1%
Net Kâr Marjı
—
INTS Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$4.54
Piyasa Değeri
$1M
P/E (TTM)
-0.0
EPS (TTM)
$-8.56
Gelir (TTM)
—
Temettü Verimi
—
ROE
-165.1%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $8
INTS Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
—
Hisse Başına Kâr
$-8.56
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
—
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
INTS
Akran Ortalaması
P/E (TTM)
-0.0
—
P/B (F/D)
0.1
1.1
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
INTS
Akran Ortalaması
ROA
-122.9%
-110.6%
ROE
-165.1%
-78.4%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
INTS
Akran Ortalaması
Current Ratio (Cari Oran)
5.9
5.7
Quick Ratio (Cari Oran)
5.6
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
INTS
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
INTS
Akran Ortalaması
INTS Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
AL
12 analist
- Güçlü Al 2 16,7%
- Al 9 75,0%
- Tut 1 8,3%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
6 analist · 2026-05-15
Medyan
$30.00
Ortalama
$41.50
← Tüm hedeflerin altında
$4.54
Düşük
$12.00
Yüksek
$125.00
Medyan hedef
$30.00
+560,8%
Ortalama hedef
$41.50
+814,1%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.39%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $-0.96 | $-1.11 | 0.15% |
| 31 Aralık 2025 | $-1.31 | $-1.27 | -0.04% |
| 30 Eylül 2025 | $-1.50 | $-2.23 | 0.73% |
| 30 Haziran 2025 | $-3.25 | $-5.04 | 1.8% |
| 31 Mart 2025 | $-5.50 | $-4.97 | -0.53% |
| 31 Aralık 2024 | $-5.50 | $-5.71 | 0.21% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| INTS | $1M | -0.0 | — | — | -165.1% | — |
| ERNA | — | — | — | — | — | — |
| MBRX | — | — | — | — | — | — |
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
| BCDA | $13M | — | -87.8% | — | 1660.5% | — |
| APRE | $7M | -0.4 | — | — | -97.5% | — |
| BIVI | — | — | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $7M | $10M | $5M | $5M | |
| SG&A Expense | $5M | $6M | $4M | $2M | |
| Operating Expenses | $12M | $17M | $8M | $8M | |
| Operating Income | $-12M | $-17M | $-8M | $-8M | |
| Interest Expense | · | · | $305.0K | $82.0K | |
| Interest Income | $180.0K | $314.0K | $324.0K | $2.0K | |
| Other Non-op | $186.0K | $3.0K | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-12M | $-16M | $-11M | $-8M | |
| EPS (Basic) | $-8.56 | $-29.24 | $-1.38 | $-2.22 | |
| EPS (Diluted) | $-8.56 | $-29.24 | $-1.38 | $-2.22 | |
| Shares (Basic) | 1,356,358 | 556,279 | 8,616,324 | 3,410,103 | |
| Shares (Diluted) | 1,356,358 | 556,279 | 8,616,324 | 3,410,103 | |
| EBITDA | $-12M | $-17M | $-8M | · |
Bilanço 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $3M | $9M | $1M | |
| Prepaid Expense | $788.0K | $773.0K | $688.0K | $63.0K | |
| Other Current Assets | · | · | $6.0K | $76.0K | |
| Current Assets | $13M | $3M | $15M | $1M | |
| Other Non-current Assets | $1M | $1M | $2M | $167.0K | |
| Total Assets | $14M | $5M | $17M | $2M | |
| Accounts Payable | $583.0K | $1M | $3M | $603.0K | |
| Accrued Liabilities | $2M | $508.0K | $891.0K | $2M | |
| Current Liabilities | $2M | $2M | $4M | $7M | |
| Capital Leases | $79.0K | $110.0K | $138.0K | $0 | |
| Other Non-current Liabilities | · | $0 | $36.0K | $36.0K | |
| Total Liabilities | $2M | $2M | $4M | $7M | |
| Common Stock | $0 | $0 | $1.0K | $0 | |
| Paid-in Capital | $90M | $70M | $64M | $24M | |
| Retained Earnings | $-78M | $-67M | $-51M | $-39M | |
| Stockholders' Equity | $12M | $3M | $13M | $-15M | |
| Liabilities + Equity | $14M | $5M | $17M | $2M | |
| Shares Outstanding | 2,524,475 | 604,915 | 13,709,377 | 3,410,103 |
Nakit Akışı 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $2M | $3M | $1M | $1M | |
| Operating Cash Flow | $-9M | $-15M | $-7M | $-5M | |
| Investing Cash Flow | $0 | $6M | $-6M | $0 | |
| Debt Issued | · | $0 | $230.0K | $2M | |
| Net Debt Issued | · | $0 | $230.0K | · | |
| Financing Cash Flow | $19M | $3M | $20M | $2M | |
| Net Change in Cash | $9M | $-6M | $7M | $-3M |
Kârlılık 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -122.9% | -147.4% | -110.6% | · | |
| ROE | -165.1% | -571.1% | -72.5% | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 5.9 | 1.9 | 3.9 | · | |
| Quick Ratio | 5.6 | 1.5 | 2.2 | · | |
| Interest Coverage | · | · | -27.3 | · |
Değerleme (TTM) 7
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-12M | $-16M | $-11M | · | |
| Market Cap | $1M | $27M | $117M | · | |
| P/E | -0.0 | -0.1 | -6.2 | · | |
| P/B | 0.1 | 9.1 | 8.9 | · | |
| P / Tangible Book | 0.1 | 9.1 | 8.9 | · | |
| P / Cash Flow | -0.1 | -1.7 | -16.3 | · | |
| Earnings Yield | -2087.8% | -1661.4% | -16.1% | · |
Gelir Tablosu 13
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $4M | $3M | $2M | $1M | $859.0K | $890.8K | |
| SG&A Expense | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $362.0K | $583.0K | |
| Operating Expenses | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $5M | $5M | $3M | $2M | $1M | $1M | |
| Operating Income | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-5M | $-5M | $-3M | $-2M | $-1M | $-1M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | · | · | $221.8K | $37.1K | |
| Interest Income | $94.0K | $89.0K | $59.0K | $17.0K | $15.0K | $28.0K | $48.0K | $98.0K | $140.0K | $176.0K | $148.0K | $0 | $156 | |
| Other Non-op | $-2.0K | $0 | $3.0K | $151.0K | $32.0K | $-6.0K | $9.0K | $0 | $0 | · | $14.0K | · | · | |
| Net Income | $-2M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-5M | $-5M | $-3M | $-2M | $-4M | $-2M | |
| EPS (Basic) | $-0.96 | $-8.15 | $-0.06 | $-0.13 | $-5.51 | $-28.29 | $-0.25 | $-0.36 | $-0.34 | $0.61 | $-0.17 | $-1.43 | $-0.44 | |
| EPS (Diluted) | $-0.96 | $-8.15 | $-0.06 | $-0.13 | $-5.51 | $-28.29 | $-0.25 | $-0.36 | $-0.34 | $0.61 | $-0.17 | $-1.43 | $-0.44 | |
| Shares (Basic) | 2,533,918 | -75,727,653 | 43,042,691 | 18,868,124 | 606,928 | -40,670,011 | 13,804,651 | 13,712,152 | 13,709,487 | -11,970,985 | 13,660,627 | 3,516,579 | 0 | |
| Shares (Diluted) | 2,533,918 | -75,727,653 | 43,042,691 | 18,868,124 | 606,928 | -40,670,011 | 13,804,651 | 13,712,152 | 13,709,487 | -11,970,985 | 13,660,627 | 3,516,579 | 0 | |
| EBITDA | $-3M | · | $-3M | $-3M | $-3M | · | $-4M | $-5M | $-5M | · | $-2M | $-1M | · |
Bilanço 19
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $12M | $7M | $2M | $929.0K | $3M | $3M | $3M | $7M | $9M | $7M | $135.8K | $1M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | $9M | · | · | |
| Prepaid Expense | $661.0K | $788.0K | $1M | $822.0K | $722.0K | $773.0K | $1M | $1M | $672.0K | $688.0K | $971.2K | · | $63.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | $14.4K | $159.5K | $76.0K | |
| Current Assets | $11M | $13M | $8M | $3M | $2M | $3M | $4M | $7M | $11M | $15M | $17M | $18M | $1M | |
| Other Non-current Assets | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $28.4K | $167.7K | $167.0K | |
| Total Assets | $12M | $14M | $10M | $4M | $3M | $5M | $5M | $9M | $12M | $17M | $17M | $18M | $2M | |
| Accounts Payable | $636.0K | $583.0K | $2M | $1M | $2M | $1M | $540.0K | $2M | $1M | $3M | $358.4K | $2M | $603.0K | |
| Accrued Liabilities | $2M | $2M | $561.0K | $941.0K | $1M | $508.0K | $2M | $1M | $1M | $891.0K | $355.0K | $1M | $2M | |
| Current Liabilities | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $4M | $724.0K | $3M | $7M | |
| Capital Leases | $70.0K | $79.0K | $87.0K | $95.0K | $102.0K | $110.0K | $117.0K | $124.0K | $131.0K | $138.0K | $144.9K | · | $0 | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | $0 | $36.0K | $36.0K | · | · | $36.0K | |
| Total Liabilities | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $3M | $3M | $4M | $904.9K | $3M | $7M | |
| Common Stock | $0 | $0 | $5.0K | $3.0K | $2.0K | $0 | $1.0K | $1.0K | $1.0K | $1.0K | $1.4K | $1.3K | $0 | |
| Paid-in Capital | $91M | $90M | $83M | $75M | $70M | $70M | $66M | $65M | $65M | $64M | $63M | $60M | $24M | |
| Retained Earnings | $-81M | $-78M | $-75M | $-73M | $-70M | $-67M | $-64M | $-60M | $-55M | $-51M | $-47M | $-45M | $-39M | |
| Stockholders' Equity | $10M | $12M | $7M | $2M | $334.0K | $3M | $3M | $5M | $10M | $13M | $16M | $15M | $-15M | |
| Liabilities + Equity | $12M | $14M | $10M | $4M | $3M | $5M | $5M | $9M | $12M | $17M | $17M | $18M | $2M | |
| Shares Outstanding | 2,540,518 | 2,524,475 | 49,068,621 | 26,166,423 | 15,264,869 | 604,915 | 13,863,947 | 13,712,877 | 13,711,877 | 13,709,377 | 13,709,377 | 13,099,377 | 3,410,103 |
Nakit Akışı 9
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $387.0K | $450.0K | $471.0K | $644.0K | $435.0K | $844.0K | $483.0K | $591.0K | $1M | $423.0K | $350.7K | $312.0K | $627.7K | |
| Operating Cash Flow | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | $-4M | $-4M | $-4M | $-946.0K | $-5M | $-239.0K | $-2M | |
| Investing Cash Flow | · | $0 | $0 | $0 | $0 | $0 | $3M | $-6.0K | $3M | $3M | $-9M | $0 | · | |
| Debt Issued | · | · | · | · | · | · | $0 | $0 | $0 | $-13.0K | $0 | $38.0K | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $0 | · | · | · | · | |
| Stock Issued | · | · | · | · | $345.0K | · | · | · | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $345.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $150.0K | $7M | $7M | $4M | $328.0K | $2M | $413.0K | $3.0K | $8.0K | $-13.0K | $21M | $-241.0K | · | |
| Net Change in Cash | $-2M | $5M | $5M | $1M | $-2M | $-192.0K | $-459.0K | $-4M | $-1M | $2M | $7M | $-480.0K | $615.7K |
Kârlılık 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -31.7% | · | -36.1% | -38.7% | -43.3% | · | -31.9% | -37.0% | -74.2% | · | -27.7% | -40.6% | · | |
| ROE | -47.2% | · | -53.4% | -67.4% | -66.6% | · | -37.6% | -48.5% | -94.7% | · | -29.3% | -48.9% | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.9 | · | 3.6 | 1.4 | 0.6 | · | 1.6 | 2.3 | 4.4 | · | 23.0 | 5.9 | · | |
| Quick Ratio | 4.6 | · | 3.1 | 1.0 | 0.4 | · | 1.2 | 1.0 | 3.0 | · | 21.6 | 0.0 | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -5.5 | · |
Değerleme (TTM) 7
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-11M | · | $-12M | $-14M | $-16M | · | $-15M | $-16M | $-12M | · | $-9M | $-9M | · | |
| Market Cap | $15M | · | $12M | $8M | $30M | · | $53M | $67M | $71M | · | $54M | $78M | · | |
| P/E | -0.9 | · | -0.4 | -0.3 | -1.7 | · | -3.4 | -2.1 | -2.2 | · | -1.6 | -2.0 | · | |
| P/B | 1.5 | · | 1.7 | 3.7 | 90.0 | · | 19.1 | 12.6 | 7.3 | · | 3.4 | 5.2 | · | |
| P / Tangible Book | 1.5 | · | 1.7 | 3.7 | 90.0 | · | 19.1 | 12.6 | 7.3 | · | 3.4 | 5.2 | · | |
| P / Cash Flow | -8.2 | · | · | · | -15.1 | · | · | · | -16.3 | · | · | · | · | |
| Earnings Yield | -113.3% | · | -271.6% | -312.7% | -59.4% | · | -29.3% | -46.9% | -44.8% | · | -63.2% | -48.8% | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Net Gelir | $-12M | $-16M | $-11M | $-8M |
| Seyreltilmiş Hisse Başı Kâr | $-8.56 | $-29.24 | $-1.38 | $-2.22 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Cari Oran | 5.9 | 1.9 | 3.9 | — |
| Cari Oran | 5.6 | 1.5 | 2.2 | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.